2014
DOI: 10.1002/jso.23636
|View full text |Cite
|
Sign up to set email alerts
|

CD30‐positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: A report of two cases and analysis of CD30 expression

Abstract: We hypothesize that ILP/ILI causes upregulation of CD30 expression in the extremities of treated patients, and suggest that this may be a marker of treatment response. However, a rare but long-term effect may be an increased risk of T-cell cutaneous lymphoproliferative disease in the affected limb.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…An association between increased latitude or distance from equator and increased prevalence of mature NK and TCL, including PC‐ALCL, perhaps suggests a modulatory effect of ultraviolet radiation . Increases in CD30+ lymphocytes have been shown in the extremities of patients given regional chemotherapy for recurrent melanoma, with at least 1 case of PC‐ALCL reported . Carbamazepine‐associated PC‐ALCL has also been documented…”
Section: Etiology and Pathogenesismentioning
confidence: 97%
“…An association between increased latitude or distance from equator and increased prevalence of mature NK and TCL, including PC‐ALCL, perhaps suggests a modulatory effect of ultraviolet radiation . Increases in CD30+ lymphocytes have been shown in the extremities of patients given regional chemotherapy for recurrent melanoma, with at least 1 case of PC‐ALCL reported . Carbamazepine‐associated PC‐ALCL has also been documented…”
Section: Etiology and Pathogenesismentioning
confidence: 97%
“…3c ) CCL17 and CCL22 to CCR4 interactions were strongest to the AXL population and these ligands have been shown to increase metastasis formation of CCR4 expressing melanoma cells ( Klein et al , 2017 ). The CD30 ligand to CD30 interaction was also higher to the AXL population, which is interesting as CD30 has been shown to be up-regulated in T-cells following malignant melanoma treatment ( Gill et al , 2014 ). The neurotensin to neurotensin receptor 2 interaction is stronger to the MITF cells, and the major source of neurotensin is endothelial cells and AXL cells.…”
Section: Resultsmentioning
confidence: 78%